Grey Fox Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Grey Fox Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8	Closed	-$5.11K	–	355
2025 Q3	$5.11K	Buy	+8	New	+$4.86K	﹤0.01%	477

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grey Fox Wealth Advisors's IDXX Position: Q4 2025 in Review

Grey Fox Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 8 shares — an estimated $5.11K sold.

Grey Fox Wealth Advisors first reported a position in IDXX in Q3 2025 and held it in 1 quarter. The position peaked at $5.11K in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Grey Fox Wealth Advisors reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Grey Fox Wealth Advisors sold 8 Idexx Laboratories shares in Q4 2025, an estimated $5.11K.
Grey Fox Wealth Advisors first reported a position in Idexx Laboratories in Q3 2025 and held it in 1 quarter.
Grey Fox Wealth Advisors's Idexx Laboratories position peaked at $5.11K in Q3 2025.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Grey Fox Wealth Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.